Mark Hopman's Insider Trades & SAST Disclosures
Mark Hopman's most recent trade in Beta Bionics Inc. was a trade of 52,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 27, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mark Hopman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Beta Bionics Inc. | Mark Hopman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 52,000 | 52,000 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Mark Hopman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 35,000 | 35,000 | - | 0 | Common Stock | |
| Beta Bionics Inc. | Mark Hopman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 83,242 | 83,242 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Mark Hopman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 47,775 | 47,775 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Mark Hopman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 39,424 | 39,424 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Mark Hopman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 37,229 | 37,229 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Mark Hopman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 17,765 | 17,765 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc. | Mark Hopman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 47,775 | 47,775 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges